http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6610075

Outgoing Links

Predicate Object
contentType Journal Article|Randomized Controlled Trial|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't
endingPage 602
issn 0271-0749
issueIdentifier 5
pageRange 597-602
publicationName Journal of Clinical Psychopharmacology
startingPage 597
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0c9844bbdee9205c4154baa99844748d
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fec02ab771d1232de9bb92feb5e0e252
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f90e3836c8e4afb1f10166e110b74082
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fd2b689b242d737bdeebf541dd22837f
bibliographicCitation Evins AE, Pachas G, Mischoulon D, Urbanoski K, Carlini S, Sousa J, Bentley K, Rigotti NA, Nino-Gomez J, Loebl T, Janes AC, Kaufman MJ, Fava M. A double-blind, placebo-controlled trial of the NMDA glycine site antagonist, GW468816, for prevention of relapse to smoking in females. J Clin Psychopharmacol. 2011 Oct;31(5):597–602. PMID: 21869693; PMCID: PMC3741043.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40cdea8d235b6ace020c546d5178c9ca
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7017-3546
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_68e3fd6f854ee23211337450046578ef
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d55aba9fdbe4425c5a78ee238b2edbe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d78f5ae7b9bbf235a981a86b9f6cf6f7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb772b13bb4494275a406353f438a850
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0bdcc60278dae0f7adac824a5d6fb754
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1714-4441
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3b8750fca6f935c158ab6b2911c6191c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a82014072b06a084340e50a81ec9d30a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e53572257ea8f73b12b6390348e617f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9896-6094
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6870ccb5d86d2024e307cd85f936753
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d44f5a867caad16d7d8f1d707cf8f745
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d378dc38ad50c1c84942c3165461e64d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_69f4f901df520704efba1805a79a3b3d
date 201110
identifier https://doi.org/10.1097/jcp.0b013e31822bb390
https://pubmed.ncbi.nlm.nih.gov/PMC3741043
https://pubmed.ncbi.nlm.nih.gov/21869693
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4660
https://portal.issn.org/resource/ISSN/0271-0749
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title A Double-Blind, Placebo-Controlled Trial of the NMDA Glycine Site Antagonist, GW468816, for Prevention of Relapse to Smoking in Females
discusses http://id.nlm.nih.gov/mesh/M0024713
http://id.nlm.nih.gov/mesh/M0018277
http://id.nlm.nih.gov/mesh/M0569367
http://id.nlm.nih.gov/mesh/M0018350
http://id.nlm.nih.gov/mesh/M0009451
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D016540Q000379
http://id.nlm.nih.gov/mesh/D011804Q000494
http://id.nlm.nih.gov/mesh/D005998Q000378
http://id.nlm.nih.gov/mesh/D011759Q000494
http://id.nlm.nih.gov/mesh/D016194Q000037
hasSubjectTerm http://id.nlm.nih.gov/mesh/D014029Q000534
http://id.nlm.nih.gov/mesh/D061485
http://id.nlm.nih.gov/mesh/D000074606
http://id.nlm.nih.gov/mesh/D011804Q000493
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D055502
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D013997
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D011759Q000493
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104813
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9331
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23327
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4525487
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14598502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5128032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9907331
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID611
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89594

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128090012
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127735632
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129261213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129583715

Total number of triples: 78.